Drug Response Profiling at KIYATEC

Complex Co-Culture Model Development

Learn about the world’s most advanced ex vivo immuno-oncology models.

Drug Response Profiling Services

3D cell culture service offerings & in vitro model development

Predicting Clinical Response

Learn more about our clinically relevant, predictive 3D response assays

KIYATEC Brochures & Posters

Recent News

Telling Cancer to Take a Hike

Tags : 

Innovation milestone is a message of authentic hope for local cancer patients By Matthew Gevaert, Ph.D., and W. Jeffrey Edenfield, MD Cancer innovation and hiking the Appalachian Trail have a few things in common. Neither happens overnight; the AT typically takes five to seven months, and meaningful innovation in cancer research can take five to

Read More

GHS and KIYATEC Announcement Video

Tags : 

Greenville Health System and Kiyatec Research announced exciting news about cancer care and treatment today.

Read More

GHS Cancer Institute, KIYATEC partner on cancer diagnostic testing

Tags : 

Staff Report – 12.14.17 The Greenville Hospital System Cancer Institute and Greenville-based KIYATEC have partnered to provide cancer patients with the diagnostic testing they need to make informed health decisions. The first of these tests to be available is one that can indicate ovarian cancer patients’ future response to chemotherapy before undergoing treatment with up to 93% accuracy, according

Read More

3 Posters @ AACR 2017 in DC

Tags : 

Three KIYATEC abstracts accepted for poster presentations during 2017 AACR Conference in Washington D.C. KIYATEC, a private company prioritizing accurate ex vivo prediction of patients’ response to drug treatment, received acceptance of three posters for presentations during the upcoming AACR conference. GREENVILLE, SC, March 21, 2017– KIYATEC Inc. is pleased to announce that three abstracts have

Read More

KIYATEC & Mayo Clinic Collaborate to Fight Ovarian Cancer

Tags : 

KIYATEC AND MAYO CLINIC COLLABORATE TO FIGHT OVARIAN CANCER Collaboration aims to validate the accuracy ex vivo 3D (EV3D) cell culture predictions against ovarian cancer patient outcomes Greenville, S.C. | June 16, 2016 07:00 EDT – KIYATEC, a leader in emerging 3D ex vivo predictive cancer diagnostics, today announced a collaboration with Mayo Clinic to

Read More

Learn More About KIYATEC